Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TTR | P02766 | 1/20 | 0.60 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.46 |
| ▸ | AURKA | O14965 | 1/20 | 0.43 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.43 |
| ▸ | CDK2 | P24941 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | NSD2 | O96028 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | IDE | P14735 | 1/20 | 0.40 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.40 |
| ▸ | CCR6 | P51684 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | COMT | P21964 | 1/20 | 0.40 |
| ▸ | ATIC | P31939 | 2/20 | 0.39 |
| ▸ | APEX1 | P27695 | 1/20 | 0.39 |
| ▸ | SNCA | P37840 | 2/20 | 0.38 |
| ▸ | CHAT | P28329 | 1/20 | 0.38 |
| ▸ | CTRB1 | P17538 | 1/20 | 0.38 |
| ▸ | ALPL | P05186 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10725694 | 0.89 | TTR (0.72) | TTRCYP1A2AURKAAURKBCDK2 | |
| SCHEMBL158215 | 0.88 | TTR (0.50) | TTRCYP1A2AURKAAURKBMEN1 | |
| SCHEMBL6242 | 0.87 | TTR (0.75) | TTRCYP1A2AURKAAURKBCDK2 | |
| SCHEMBL30233642 | 0.87 | TTR (0.75) | TTRCYP1A2AURKAAURKBCDK2 | |
| SCHEMBL29363198 | 0.87 | TTR (0.75) | TTRCYP1A2AURKAAURKBCDK2 | |
| Ammonia Solution, Strong SCHEMBL25312340 | 0.84 | TTR (0.72) | TTRCYP1A2AURKAAURKBCDK2 | |
| Lithium SCHEMBL18420655 | 0.84 | TTR (0.72) | TTRCYP1A2AURKAAURKBCDK2 | |
| Ammonia Solution, Strong SCHEMBL10954121 | 0.84 | TTR (0.72) | TTRCYP1A2AURKAAURKBCDK2 | |
| Hydrochloric Acid SCHEMBL7455908 | 0.84 | TTR (0.72) | TTRCYP1A2AURKAAURKBCDK2 | |
| SCHEMBL460184 | 0.84 | TTR (0.72) | TTRCYP1A2AURKAAURKBCDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5021557-A | Copper-containing formazan dye, colorfast blue shades on cellulose | CIBA-GEIGY CORPORATION (US) | 1991-06-04 | — | — | US | claimed |
| EP-2633088-B1 | NON METAL TANNING | STAHL INT B V (NL) | 2018-09-12 | — | — | EP | disclosed |
| EP-2633086-B1 | NON-METAL TANNING PROCESS | STAHL INT B V (NL) | 2017-08-16 | — | — | EP | disclosed |
| EP-2633089-B1 | NON METAL TANNING | STAHL INT B V (NL) | 2017-03-15 | — | — | EP | disclosed |
| EP-2638181-B1 | NON METAL TANNING | STAHL INT B V (NL) | 2017-02-22 | — | — | EP | disclosed |
| EP-2638179-B1 | NON METAL TANNING | STAHL INT BV (NL) | 2014-11-26 | — | — | EP | disclosed |
| EP-2638180-B1 | NON METAL TANNING | STAHL INT BV (NL) | 2014-11-26 | — | — | EP | disclosed |
| EP-2633087-B1 | NON-METAL TANNING PROCESS | STAHL INT BV (NL) | 2014-09-17 | — | — | EP | disclosed |
| US-8808398-B2 | Non metal tanning | STAHL INTERNATIONAL B.V. (NL) | 2014-08-19 | — | — | US | disclosed |
| US-8801804-B2 | Non-metal tanning process | STAHL INTERNATIONAL B.V. (NL) | 2014-08-12 | — | — | US | disclosed |
| US-20100221502-A1 | Anthrapyridone Compound and Salt Thereof, Magenta Ink Composition Containing the Anthrapyridone Compound, and Colored Article | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2010-09-02 | — | — | US | disclosed |
| US-20100209678-A1 | ANTHRAPYRIDONE COMPOUND OR SALT THEREOF, MAGENTA INK COMPOSITION AND COLORED PRODUCT | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2010-08-19 | — | — | US | disclosed |
| EP-2206747-A1 | ANTHRAPYRIDONE COMPOUND, SALT THEREOF, MAGENTA INK COMPOSITION AND COLORED BODY | Nippon Kayaku Kabushiki Kaisha (JP) | 2010-07-14 | — | — | EP | disclosed |
| US-7223301-B2 | Anthrapyridone compound, water-based magenta ink composition and inkjet recording method | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2007-05-29 | — | — | US | disclosed |
| US-20060219131-A1 | Anthrapyridone compound, aqueous magenta ink composition and inkjet recording method | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2006-10-05 | — | — | US | disclosed |
| EP-1626069-A1 | ANTHRAPYRIDONE COMPOUND, AQUEOUS MAGENTA INK COMPOSITION AND INKJET RECORDING METHOD | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2006-02-15 | — | — | EP | disclosed |
| EP-1315695-B1 | BENZENE TRICARBOXYLIC ACID AMIDES AS INSULIN RECEPTOR ACTIVATORS | TELIK INC (US) | 2005-07-13 | — | — | EP | disclosed |
| US-6600069-B2 | Insulin receptor kinase activators; treating hyperglycemia; 4-((3,5-bis(N-(4-sulfophenyl)carbamoyl)phenyl)carbonylamino)-benzenesulfonic acid, for example | TELIK, INC. | 2003-07-29 | — | — | US | disclosed |
| US-5118826-A | Colorfastness | CIBA-GEIGY CORPORATION (US) | 1992-06-02 | — | — | US | disclosed |
| US-5021557-A | Copper-containing formazan dye, colorfast blue shades on cellulose | CIBA-GEIGY CORPORATION (US) | 1991-06-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100209678-A1 | ANTHRAPYRIDONE COMPOUND OR SALT THEREOF, MAGENTA INK COMPOSITION AND COLORED PRODUCT | RB1, ATXN2, ATXN10 | TTR 1061/4885CYP1A2 1893/4885AURKA 4/4885 |
| US-20100221502-A1 | Anthrapyridone Compound and Salt Thereof, Magenta Ink Composition Containing the Anthrapyridone Compound, and Colored Article | ABL1, ATXN2L, ANXA7 | TTR 2302/4885CYP1A2 772/4885AURKA 4/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.